1. Home
  2. ITGR vs WVE Comparison

ITGR vs WVE Comparison

Compare ITGR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integer Holdings Corporation

ITGR

Integer Holdings Corporation

HOLD

Current Price

$88.97

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.99

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITGR
WVE
Founded
1970
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
ITGR
WVE
Price
$88.97
$6.99
Analyst Decision
Buy
Strong Buy
Analyst Count
7
16
Target Price
$91.14
$29.81
AVG Volume (30 Days)
515.2K
3.9M
Earning Date
04-30-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.48
N/A
Revenue
$1,853,637,000.00
$3,704,000.00
Revenue This Year
$1.69
N/A
Revenue Next Year
$6.53
$85.67
P/E Ratio
$177.19
N/A
Revenue Growth
7.98
149.43
52 Week Low
$62.00
$5.02
52 Week High
$123.78
$21.73

Technical Indicators

Market Signals
Indicator
ITGR
WVE
Relative Strength Index (RSI) 56.40 39.50
Support Level $82.58 $6.81
Resistance Level $89.20 $7.65
Average True Range (ATR) 3.86 0.37
MACD 0.17 0.11
Stochastic Oscillator 83.56 27.17

Price Performance

Historical Comparison
ITGR
WVE

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: